BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31, 2018.
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2019 ,inter alia, to consider and approve the following agenda: a) the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2018; and b) proposal for establishment of Employee Stock Option Plan scheme. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from Monday, January 21, 2019 to Thursday, January 31, 2019 (both days inclusive). Kindly acknowledge and take on record the same.19-01-2019